Helping Make Your Chemical Research Possible

While currently designated as scheduled substances in many countries, some psychedelics are demonstrating medical benefits in clinical studies examining treatment of diseases that are resistant to other therapies. For research and regulatory compliance in the use of these compounds, Caymans has a range of reference standards available as parent drugs, metabolites, degradants, and structurally related compounds in both their native and stable isotope forms. Our chemists manufacture both well-known and novel compounds in our DEA-regulated facilities. Larger quantities, custom synthesis and formulations, and characterization can be requested, and our Medicinal Chemistry & Structural Biology services offer a fully integrated, multidisciplinary approach to help you identify new targets for pharmaceutical drug discovery.